Latest Strategic Investment News

Atomo Diagnostics capitalises on Lumos Diagnostics’ FebriDx FDA CLIA waiver with over $2 million in new sales orders and a $3 million capital raise, expanding its global footprint and product pipeline.

Imricor Medical Systems advanced FDA clearances and expanded clinical trials in Q1 CY26, positioning for commercial growth despite higher operating cash outflows.

Carnarvon Energy is gearing up for a high-impact Bedout Sub-basin drilling campaign in the first half of 2027, supported by a robust balance sheet and strategic investments.

TruScreen Group has met its FY2026 revenue guidance with a 41% jump in product sales, while investing heavily in new markets and pursuing a major UNITAID funding bid that could reshape its medium-term outlook.

Island Pharmaceuticals has cleared a major regulatory hurdle with the US FDA, confirming a clinical development path for its antiviral Galidesivir under the Animal Rule. Backed by a $9 million capital raise and strategic partnerships, the company is poised for potential US government procurement and biodefence market entry.

Altair Minerals has landed a A$28.2 million strategic placement from Endeavour Mining’s subsidiary at a premium, boosting its treasury to about A$40 million and enabling a major expansion of exploration at the Greater Oko gold project in Guyana.

Wrkr Ltd has successfully launched its Rest Pay and AustralianSuper platforms, onboarding over 6,000 organisations and processing $100 million in contributions as it prepares for the July 2026 Payday Super legislative deadline.

Qube Holdings Limited is set for a $9.3 billion cash takeover by a Macquarie-led consortium, with court approval granted to convene shareholder meetings in June. The scheme offers shareholders a 28% premium and is backed by an independent expert's fair and reasonable opinion.

DigitalX Limited closed the March 2026 quarter with A$59.5 million in liquid assets, unveiling a A$30 million strategic investment program and delivering record revenue from its Sell My Shares platform, signalling a pivot towards disciplined capital deployment and sustainable growth.

Fenix Resources shipped 974,000 tonnes of iron ore in March quarter at a low A$70/wmt cash cost despite cyclone disruptions and diesel supply constraints, boosting cash to A$86.3 million and advancing key projects.

Black Cat Syndicate posted solid operating cash flow of A$61 million in the March quarter, driven by the ramp-up at Kal East and a strategic $20 million expansion of the Lakewood processing facility. The company also reported a 95% increase in antimony resources at Mt Clement, signaling growth potential beyond gold.

Perseus Mining delivered a strong March quarter with a 21% jump in gold production and a cash pile swelling to US$817 million, while confirming the completion of its US$260 million Meyas Sand Project sale. The Nyanzaga development remains on track for first gold in January 2027.